Literature DB >> 19392844

Salvage esophagectomy after definitive chemoradiotherapy for synchronous double cancers of the esophagus and head-and-neck.

R Yoshida1, M Morita, K Ando, T Masuda, H Saeki, E Oki, N Sadanaga, T Nakashima, Y Kakeji, Y Maehara.   

Abstract

Head-and-neck cancer is frequently associated with esophageal cancer. Because the operative procedures for these synchronous double cancers are too invasive, definitive chemoradiotherapy tends to be applied as an initial treatment. A salvage esophagectomy for either recurrent or residual disease after definitive chemoradiotherapy in patients with such double cancer has never been reported. We reviewed 21 patients with esophageal cancer who underwent a salvage esophagectomy after definitive chemoradiotherapy. Among them, the treatment course of five patients who underwent a salvage esophagectomy for patients with synchronous double cancers of the esophagus and head-and-neck region was analyzed. Because head-and-neck cancer was well controlled after chemoradiotherapy in all five patients, a salvage esophagectomy was indicated for either recurrent or residual esophageal cancer after definitive chemoradiotherapy. Anastomotic leakage developed in four patients; however, no other complications including pulmonary complications were recognized. All of them were discharged to home and three of them are still alive without any recurrence for 20-43 months. A salvage esophagectomy should be considered as a treatment option for either recurrent or residual esophageal cancer with well-controlled head-and-neck cancer after definitive chemoradiotherapy when complete resection of the esophagus is expected.

Entities:  

Mesh:

Year:  2009        PMID: 19392844     DOI: 10.1111/j.1442-2050.2009.00973.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  4 in total

1.  Treatment outcomes for one-stage concurrent surgical resection and reconstruction of synchronous esophageal and head and neck squamous cell carcinoma.

Authors:  Yu-Hsuan Lin; Chun-Yen Ou; Wei-Ting Lee; Yao -Chou Lee; Tzu -Yen Chang; Yi-Ting Yen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-22       Impact factor: 2.503

Review 2.  Surgical strategies for esophageal cancer associated with head and neck cancer.

Authors:  Masaru Morita; Hiroshi Saeki; Shuhei Ito; Yasue Kimura; Nami Yamashita; Koji Ando; Yukiharu Hiyoshi; Eriko Tokunaga; Eiji Oki; Tetsuo Ikeda; Sei Yoshida; Torahiko Nakashima; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-08-30       Impact factor: 2.549

3.  Treatment of Squamous Cell Carcinoma of the Esophagus Synchronously Associated with Head and Neck Cancer.

Authors:  Masaru Morita; Akinori Egashira; Y U Nakaji; Masaki Kagawa; Masahiko Sugiyama; Daisuke Yoshida; Mitsuhiko Ota; Masahiko Ikebe; Muneyuki Masuda; Yojiro Inoue; Naonobu Kunitake; Yasushi Toh
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

4.  Long-term treatment results and prognostic factors of synchronous and metachronous squamous cell carcinoma of head and neck and esophagus.

Authors:  Jiali Chen; Chunying Shen; Chaosu Hu; Cuihong Wang; Yongxue Zhu; Xueguan Lu
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.